🔎 Trials Near Me

መነሻ › የእንቁላል ካንሰር › ሉዊዚያና › New Orleans

በNew Orleans፣ LA ለየእንቁላል ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች

ለየእንቁላል ካንሰር የሚደረጉ 12 ጥናቶች በNew Orleans እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Louisiana State University HSC - NO Cancer Center, New Orleans
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ5 ኦክቶ 2026 · NCT06915025

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

ተሳታዮችን በመፈለግ ላይደረጃ 2/3
  • University Medical Center New Orleans, New Orleans
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT07001748

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Ochsner Medical Center Jefferson, New Orleans
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT05564377

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Ochsner Clinic Foundation, New Orleans
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT05051722

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University Medical Center New Orleans /ID# 274755, New Orleans
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT06890338

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Ochsner Clinic Foundation, New Orleans
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07213804

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Tulane Cancer Center, New Orleans
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT05059444

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

ተሳታዮችን በመፈለግ ላይ
  • Louisiana State University Health Science Center, New Orleans
  • University Medical Center New Orleans, New Orleans
  • West Jefferson Medical Center, Marrero · 4 ማይል ርቀት
እድሜ ከ35 እስከ 50 · ሴቶች · የተሻሻለው በ7 ኦገስ 2026 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • University Medical Center New Orleans, New Orleans
  • Ochsner Baptist Medical Center, New Orleans
  • Ochsner Medical Center Jefferson, New Orleans
  • እና 1 ተጨማሪ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ7 ኦገስ 2026 · NCT06580314

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Louisiana State University Health Sciences Center, New Orleans
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ7 ጁላይ 2026 · NCT05768139

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • LSU Health New Orleans, New Orleans
  • University Medical Center New Orleans, New Orleans
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ16 ኤፕሪ 2026 · NCT05659381

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Massive Bio SYNERGY-AI site, New Orleans
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦክቶ 2025 · NCT03452774

በሌሎች ከተሞች ለየእንቁላል ካንሰር የሚደረጉ ጥናቶች

በNew Orleans ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።